Balyasny Asset Management LLC Boston Scientific Corp Transaction History

Balyasny Asset Management LLC

$57.8 Billion
Q1 2025

A detailed history of Balyasny Asset Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 4,500 shares of BSX stock, worth $461,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,500

Previous 26,100 82.76%

Holding current value

$461,880

Previous $2.33 Million 80.57%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$89.38 - $106.18 $6.4 Million - $7.6 Million	71,571 Added 4.05%	1,838,179 $185 Million
Q4 2024 Feb 14, 2025	SELL	$83.62 - $91.5 $141 Million - $155 Million	-1,688,996 Reduced 48.88%	1,766,608 $158 Million
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $39.4 Million - $45.3 Million	539,531 Added 18.5%	3,455,604 $290 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $89.1 Million - $103 Million	1,322,739 Added 83.02%	2,916,073 $225 Million
Q1 2024 May 13, 2024	BUY	$57.6 - $68.62 $15 Million - $17.9 Million	260,778 Added 19.57%	1,593,334 $109 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $64.4 Million - $76.6 Million	1,324,980 Added 17489.18%	1,332,556 $77 Million
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $568,953 - $619,852	-11,336 Reduced 59.94%	7,576 $400,000
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $28.6 Million - $31.4 Million	-575,106 Reduced 96.82%	18,912 $1.02 Million
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $26.8 Million - $29.7 Million	594,018 New	594,018 $29.7 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $42.7 Million - $128 Million	1,163,565 Added 98.29%	2,347,335 $90.9 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $24.9 Million - $33.3 Million	707,487 Added 148.54%	1,183,770 $44.1 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $19.5 Million - $21.5 Million	476,283 New	476,283 $21.1 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $82.1 Million - $96.7 Million	-2,155,328 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $17.5 Million - $19.4 Million	423,352 Added 24.44%	2,155,328 $93.5 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $61.1 Million - $70.1 Million	1,583,798 Added 1068.85%	1,731,976 $74.1 Million
Q2 2020 Aug 14, 2020	SELL	$30.19 - $39.11 $61.3 Million - $79.5 Million	-2,031,758 Reduced 93.2%	148,178 $5.2 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $47.9 Million - $84.7 Million	1,853,465 Added 567.73%	2,179,936 $71.1 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $12.4 Million - $14.8 Million	326,471 New	326,471 $14.8 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $21.5 Million - $26.5 Million	-616,675 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $20.3 Million - $25.1 Million	616,675 New	616,675 $23.7 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $14.9 Million - $18.3 Million	-468,618 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $10.8 Million - $12.7 Million	-327,892 Reduced 41.17%	468,618 $18 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $17.9 Million - $22.9 Million	668,139 Added 520.48%	796,510 $26 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $20.4 Million - $23.1 Million	-808,738 Reduced 86.3%	128,371 $3.51 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $1.11 Million - $1.34 Million	-44,815 Reduced 4.56%	937,109 $23.2 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $25.8 Million - $28.6 Million	981,924	981,924 $28.6 Million

Others Institutions Holding BSX

# of Institutions

1,880

Shares Held

1.22B

Call Options Held

9.46M

Put Options Held

7.03M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $147B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Boston Scientific Corp Transaction History